Research | OneLook Acronym Finder |
Serial Number | 79043515 |
Registration Number | 3591359 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Domestic Representative | Adrienne L. White |
Attorney Name | Adrienne L. White |
Attorney Docket Number | 000337-013 |
Law Office Assigned | M60 |
Employee Name | FRENCH, CURTIS W |
2007-04-27 | Application Filed |
2008-12-30 | Published for Opposition |
2009-03-17 | Trademark Registered |
2015-03-23 | Location: GENERIC WEB UPDATE |
2015-03-23 | Status: Live/Registered |
2018-07-08 | Transaction Date |
Owner: | MediGene AG |
Entity Statement | Aktiengesellschaft |
Address | Lochhamer Strasse 11 82152 Planegg DE |
Legal Entity Type | |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Medicines for humans and animals, except venous-therapeutics, namely, medicines for treating [ cardiovascular and vascular diseases, ] dermatological disorders and diseases, [ precancerous diseases, benign and malignant tumors, infectious diseases, allergic and asthmatic diseases, neurodegenerative diseases, autoimmune diseases, diseases of the respiratory tract, gastrointestinal diseases, blood disorders, aging-associated diseases, genetic disorders, metabolic disorders, musculoskeletal disorders and eye diseases, vaccines for treating cardiovascular and vascular diseases, dermatological disorders and diseases, precancerous diseases, benign and malignant tumors, infectious diseases, allergic and asthmatic diseases, neurodegenerative diseases, autoimmune diseases, diseases of the respiratory tract, gastrointestinal diseases, blood disorders, aging-associated diseases, genetic disorders, metabolic disorders, musculoskeletal disorders and eye diseases; serums, namely, immune serums for passive vaccination for treating infectious diseases, diagnostic test kits comprising antibodies, antibody fragments, serums, soluble monoclonal T-cell receptors, peptides, peptide-analogues, enzymes, liposomes, dyes, radioactively labeled substances, for the purpose of testing, diagnosing and monitoring cardiovascular and vascular diseases, dermatological disorders and diseases, precancerous diseases, benign and malignant tumors, infectious diseases, allergic and asthmatic diseases, neurodegenerative diseases, autoimmune diseases, diseases of the respiratory tract, gastrointestinal diseases, blood disorders, aging-associated diseases, genetic disorders, metabolic disorders, musculoskeletal disorders and eye diseases; proteins, proteinconjugates, peptides, enzymes and enzyme-preparations, antibodies, T-cell-proteins, attenuated viruses, virus-like particles, liposomes, ] herbal extracts, components of low molecular weight, all for use as medicines [, vaccines and parts of medical diagnostic test kits for treating, testing, diagnosing and monitoring all diseases mentioned above ] |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2007-10-11 | 1 REPR M: |
NEW APPLICATION ENTERED IN TRAM | 2007-10-12 | 2 NWAP I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2007-10-12 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2007-10-24 | 4 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2007-10-25 | 5 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2007-10-25 | 6 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2007-10-26 | 7 RFCS P: |
REFUSAL PROCESSED BY IB | 2007-11-16 | 8 RFNT P: |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2008-04-28 | 9 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2008-04-28 | 10 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2008-04-28 | 11 TEME I:Incoming Correspondence |
NON-FINAL ACTION WRITTEN | 2008-05-21 | 12 CNRT R:Renewal |
NON-FINAL ACTION MAILED | 2008-05-21 | 13 CNRT O:Outgoing Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2008-11-17 | 14 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2008-11-17 | 15 ARAA I:Incoming Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2008-11-17 | 16 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2008-11-17 | 17 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2008-11-18 | 18 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2008-11-20 | 19 CNSA O:Outgoing Correspondence |
ASSIGNED TO LIE | 2008-11-25 | 20 ALIE A:Allowance for Publication |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2008-11-25 | 21 PREV O:Outgoing Correspondence |
NOTICE OF PUBLICATION | 2008-12-10 | 22 NPUB O:Outgoing Correspondence |
PUBLISHED FOR OPPOSITION | 2008-12-30 | 23 PUBO A:Allowance for Publication |
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2009-03-12 | 24 OPNR P: |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2009-03-12 | 25 OPNS P: |
REGISTERED-PRINCIPAL REGISTER | 2009-03-17 | 26 R.PR A:Allowance for Publication |
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2009-03-27 | 27 OPNX P: |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2009-06-17 | 28 FICR P: |
FINAL DISPOSITION PROCESSED | 2009-07-01 | 29 FIMP P: |
FINAL DISPOSITION NOTICE SENT TO IB | 2009-07-01 | 30 FICS P: |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-11-24 | 31 TCCA I:Incoming Correspondence |
FINAL DECISION TRANSACTION PROCESSED BY IB | 2013-01-12 | 32 FINO P: |
TEAS SECTION 71 & 15 RECEIVED | 2015-03-17 | 33 ES75 I:Incoming Correspondence |
CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2015-03-23 | 34 APRE A:Allowance for Publication |
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | 2015-03-23 | 35 C75A O:Outgoing Correspondence |
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | 2015-03-23 | 36 NA75 E:E-Mail |
INTERNATIONAL REGISTRATION RENEWED | 2017-05-11 | 37 RNWL P: |
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | 2018-03-17 | 38 REM4 E:E-Mail |
NEW REPRESENTATIVE AT IB RECEIVED | 2018-08-23 | 39 NREP P: |
CANCELLED SECTION 71 | 2021-02-26 | 40 C71T O:Outgoing Correspondence |
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | 2021-10-26 | 41 INTR P: |
INVALIDATION PROCESSED | 2021-12-01 | 42 INPC P: |
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | 2021-12-01 | 43 INTS P: |
TOTAL INVALIDATION PROCESSED BY THE IB | 2022-01-09 | 44 INNT P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.